Bevacizumab may differentially improve ovarian cancer...

  • Main
  • 2017 / 02
  • Bevacizumab may differentially improve ovarian cancer...

Bevacizumab may differentially improve ovarian cancer outcome in patients with proliferative and mesenchymal molecular subtypes

Kommoss, Stefan, Winterhoff, Boris, Oberg, Ann, Konecny, Gottfried E., Wang, Chen, Riska, Shaun M, Fan, Jian-Bing, Maurer, Matthew J., April, Craig, Shridhar, Viji, Kommoss, Friedrich, du Bois, Andrea
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-2196
Date:
February, 2017
File:
PDF, 510 KB
english, 2017
Conversion to is in progress
Conversion to is failed